EU clears Pfizer's $43 bn takeover of biotech firm Seagen

Pfizer announced in March its deal with Seagen, which is based in Washington state and leads in the research, development and commercialisation of cancer treatments.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/w9PHirv
via